Drug Database
Back to search

Netherlands· NL-f7ec7d99f7c9

Jorveza 0,2 mg/ml suspensie voor oraal gebruik

A budesonide product containing budesonide, registered in Netherlands by Dr. Falk Pharma GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC A07EA06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedJorveza 0,2 mg/ml suspensie voor oraa…ATCA07EA06REGISTER NO.NL-f7ec7d99f7c9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about budesonideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Budesonide is registered in 16 of 19 countries.

Countries holding a registration under ATC A07EA06 (budesonide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search budesonide products by name

Budesonide · ATC A07EA06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of budesonide costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $2.36 in Italy to $4.97 in Switzerland — a ×2.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Budesonide · price per daily dose (9 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.97
  • IT Italy$2.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUDESONIDE
Manufacturer
Dr. Falk Pharma GmbH
Country
Netherlands (NL)
ATC code
A07EA06
ATC class
Budesonide
Defined daily dose
9 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1254

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

687 interactions on record for budesonide.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check budesonide against other medicinesHow interaction checks work

Budesonide · interactions on record

687 records

  • 62 severe
  • 260 moderate
  • 27 minor
  • 337 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • Bempedoic acidC10AX15severe
  • MifepristoneG03XB01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Budesonide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All budesonide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Budenofalk, Budo-San
  • Belgium · Budenofalk, Budesonid Sandoz
  • Bulgaria · Airbudenid, Буденофалк
  • Cyprus · Axelovert, Biosonide
  • Czechia · Budenofalk, Budenofalk Uno
  • Germany · Aquacort, Budapp Nasal
  • Denmark · Benarhin, Budenofalk
  • Estonia · Budesonid Sandoz, Budesonide
  • Spain · Budena, Budesonida
  • Finland · Budenofalk, Budesonid Easyhaler Orion
  • France · Budésonide Arrow, Budesonide Biogaran
  • United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
  • Greece · Aurid, Axelovert
  • Croatia · Budelin Novolizer, Budosan
  • Hungary · Budenofalk, Budesonid Easyhaler
  • Ireland · Budenofalk, Budesonide Azure
  • Iceland · Budesonide Stada, Cortiment
  • Italy · Aircort, Bidien
  • Liechtenstein · Jorveza, Kinpeygo
  • Lithuania · Budenofalk, Budesonide Ferring
  • Luxembourg · Budenofalk, Budesonide Eg
  • Latvia · Budenofalk, Budesonid Sandoz
  • Malta · Budesonida Aldo-Unión, Budesonide Azure
  • Norway · Budenofalk, Budesonid Medical Valley
  • Poland · Bds N, Benodil
  • Portugal · Aeromax, Budenofalk
  • Romania · Budenofalk, Budenofalk Uno
  • Sweden · Budaxiro, Budenofalk
  • Slovenia · Budenofalk, Budesonid Easyhaler Orion
  • Slovakia · Budelin Novolizer, Budenofalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6aed99d9-a950-43b9-a7e6-c29185e9c491
GET /v1/drugs/6aed99d9-a950-43b9-a7e6-c29185e9c491?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/jorveza-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Budesonide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp134974",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "DINATRIUMEDETAAT 2-WATER",
    "METHYLCELLULOSE 1500 mPa.s",
    "NATRIUMBENZOAAT (E 211)",
    "SACCHAROSE",
    "WATER, GEZUIVERD",
    "ZWARTEBESSENSMAAKSTOF"
  ],
  "substances": [
    "BUDESONIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/04/08",
  "procedure_number": "EMEA/H/C/004655",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1254",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about budesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console